Metabolomics in Lipoid Proteinosis

Author(s): Ataman Gonel*, Ismail Koyuncu, Mustafa Aksoy, Hakim Celik

Journal Name: Current Metabolomics and Systems Biology
Formerly Current Metabolomics

Volume 7 , Issue 1 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: Lipoid proteinosis (LP) is an autosomal recessive transfer lysosomal storage disease that is characterized by the accumulation of hyalin substance in the mucous membranes, skin, internal organs, and brain. Thus far, no biochemical diagnostic method has been identified.

Objective: The aim of this study was to determine the carnitine and acylcarnitine metabolic profiles of LP patients and to examine the potential of LC-MS/MS as a new biochemical method for the identification of biochemical markers.

Methods: In this study, 27 carnitine and acylcarnitine esters were measured with LCMS/ MS in serum samples taken from 14 healthy control subjects and 14 patients. The patients, who presented at the Skin and Venereal Diseases Polyclinic, were diagnosed with LP on the basis of clinical, radiological, and histopathological examinations.

Results: The results of the study showed that the C0 (free carnitine) C3, C4, C4:DC, C5DC, C6, C8, C14:1, C14:2, C16, and C18 acylcarnitines were statistically significantly reduced in the LP patients (p < 0.05, p < 0.01).

Conclusion: It was concluded that the application of carnitine profile screening, an inexpensive, rapid, and reliable method, as a supporting laboratory test could make a contribution to the differential diagnosis for individuals with suspected LP.

Keywords: LC-MS/MS, lipoid proteinosis, carnitine, acylcarnitine, suspected LP, metabolomics.

[1]
McGrath, J.A. In Handbook of clinical neurology; Elsevier, 2015, Vol. 132, pp. 317-322.
[2]
Xu, W.; Wang, L.; Zhang, L.; Han, D.; Zhang, L. Otolaryngological manifestations and genetic characteristics of lipoid proteinosis. Ann. Otol. Rhinol. Laryngol., 2010, 119(11), 767-771.
[PMID: 21140637]
[3]
Van Hougenhouck-Tulleken, W.; Chan, I.; Hamada, T.; Thornton, H.; Jenkins, T.; McLean, W.H.; McGrath, J.A.; Ramsay, M. Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa. Br. J. Dermatol., 2004, 151(2), 413-423.
[http://dx.doi.org/10.1111/j.1365-2133.2004.06076.x] [PMID: 15327549]
[4]
Hamie, L.; Knio, Z.; Abbas, O.; Akel, R.; Bardawil, T.; Kibbi, A.G.; Kurban, M. Clinical clues early in the lives of individuals with lipoid proteinosis can determine the course of the disease. Clin. Exp. Dermatol., 2017, 42(4), 428-430.
[http://dx.doi.org/10.1111/ced.13075] [PMID: 28244239]
[5]
Youssefian, L.; Vahidnezhad, H.; Daneshpazhooh, M.; Abdollahzadeh, S.; Talari, H.; Khoshnevisan, A.; Chams-Davatchi, C.; Mobasher, R.; Li, Q.; Uitto, J.; Akhondzadeh, S.; Tabrizi, M. Lipoid proteinosis: phenotypic heterogeneity in Iranian families with c.507delT mutation in ECM1. Exp. Dermatol., 2015, 24(3), 220-222.
[http://dx.doi.org/10.1111/exd.12620] [PMID: 25529926]
[6]
Hamada, T.; McLean, W.H.; Ramsay, M.; Ashton, G.H.; Nanda, A.; Jenkins, T.; Edelstein, I.; South, A.P.; Bleck, O.; Wessagowit, V.; Mallipeddi, R.; Orchard, G.E.; Wan, H.; Dopping-Hepenstal, P.J.; Mellerio, J.E.; Whittock, N.V.; Munro, C.S.; van Steensel, M.A.; Steijlen, P.M.; Ni, J.; Zhang, L.; Hashimoto, T.; Eady, R.A.; McGrath, J.A. Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum. Mol. Genet., 2002, 11(7), 833-840.
[http://dx.doi.org/10.1093/hmg/11.7.833] [PMID: 11929856]
[7]
Rienstra, M.; McManus, D.D.; Benjamin, E.J. Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making? Circulation, 2012, 125(20), e941-e946.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.112920] [PMID: 22615425]
[8]
Liu, Y.; Yan, S.; Ji, C.; Dai, W.; Hu, W.; Zhang, W.; Mei, C. Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury. Kidney Blood Press. Res., 2012, 35(5), 373-381.
[http://dx.doi.org/10.1159/000336171] [PMID: 22487906]
[9]
Patti, G.J.; Yanes, O.; Siuzdak, G. Innovation: Metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol., 2012, 13(4), 263-269.
[http://dx.doi.org/10.1038/nrm3314] [PMID: 22436749]
[10]
Wang, Q.; Sun, T.; Cao, Y.; Gao, P.; Dong, J.; Fang, Y.; Fang, Z.; Sun, X.; Zhu, Z. A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection. OncoTargets Ther., 2016, 9, 1389-1398.
[PMID: 27042107]
[11]
Barone, R.; Alaimo, S.; Messina, M.; Pulvirenti, A.; Bastin, J.; Ferro, A.; Frye, R.E.; Rizzo, R.; Fiumara, A.; Meli, C. A subset of patients with Autism Spectrum Disorders show a distinctive metabolic profile by dried blood spot analyses. Front. Psychiatry, 2018, 9, 636.
[http://dx.doi.org/10.3389/fpsyt.2018.00636] [PMID: 30581393]
[12]
Jing, Y.; Wu, X.; Gao, P.; Fang, Z.; Wu, J.; Wang, Q.; Li, C.; Zhu, Z.; Cao, Y. Rapid differentiating colorectal cancer and colorectal polyp using dried blood spot mass spectrometry metabolomic approach. IUBMB Life, 2017, 69(5), 347-354.
[http://dx.doi.org/10.1002/iub.1617] [PMID: 28322027]
[13]
Hu, Z.; Zhu, Z.; Cao, Y.; Wang, L.; Sun, X.; Dong, J.; Fang, Z.; Fang, Y.; Xu, X.; Gao, P.; Hongzhi, S. Rapid and sensitive differentiating ischemic and hemorrhagic strokes by dried blood spot based direct injection mass spectrometry metabolomics analysis. J. Clin. Lab. Anal., 2016, 30(6), 823-830.
[http://dx.doi.org/10.1002/jcla.21943] [PMID: 27278546]
[14]
Koyuncu, I.; Gonel, A. Rapid and sensitive determination of carnitine profiling by tandem mass spectrometry can be a diagnostic marker of paroxys-mal atrial fibrillation. J. Clin. Anal. Med., 2018, 9(5), 447-451.
[http://dx.doi.org/10.4328/JCAM.5815]
[15]
Bravo, C.; Hua, S.; Clish, C.B.; Scott, J.; Deik, A.; Kaplan, R.C.; Lazar, J.; Anastos, K.; Robles, O.A.; Kizer, J. Metabolomics Profiling Of Left Ven-tricular Diastolic Dysfunction In Women With, Or At Risk For HIV Infection: The Women’s Interagency HIV Study. J. Am. Coll. Cardiol., 2018, 71(11)(Suppl.), A803.
[http://dx.doi.org/10.1016/S0735-1097(18)31344-5]
[16]
Azzari, C.; la Marca, G.; Resti, M. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry. J. Allergy Clin. Immunol., 2011, 127(6), 1394-1399.
[http://dx.doi.org/10.1016/j.jaci.2011.03.040] [PMID: 21624616]
[17]
La Marca, G.; Malvagia, S.; Pasquini, E.; İnnocenti, M.; Fernandez, M.R.; Donati, M.A.; Zammarchi, E. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. Rapid Commun. Mass Spectrom., 2008, 22(6), 812-818.
[http://dx.doi.org/10.1002/rcm.3428] [PMID: 18278819]
[18]
Celik, M.; Şen, A.; Koyuncu, İ.; Gönel, A. Plasma-free amino acid profiling of nasal polyposis patients. Comb. Chem. High Throughput Screen., 2019.
[http://dx.doi.org/10.2174/1386207322666190920110324] [PMID: 31538890]
[19]
Sağlık, A.; Koyuncu, İ.; Soydan, A.; Sağlık, F.; Gönel, A. Tear organic acid analysis after corneal collagen crosslinking in keratoconus. Eye Contact Lens, 2019.
[PMID: 31425352]
[20]
Saglik, A.; Koyuncu, I.; Yalcin, H.; Adibelli, F.M.; Gonel, A.; Toptan, M. Carnitine analysis in pterygium. Arq. Bras. Oftalmol., 2019. S0004-27492019005014101
[PMID: 31531547]
[21]
Saglik, A.; Koyuncu, I.; Gonel, A.; Yalcin, H.; Adibelli, F.M.; Toptan, M. Metabolomics analysis in pterygium tissue. Int. Ophthalmol., 2019, 1-9.
[PMID: 30617855]
[22]
Bremer, J. Carnitine-metabolism and functions. Physiol. Rev., 1983, 63(4), 1420-1480.
[http://dx.doi.org/10.1152/physrev.1983.63.4.1420] [PMID: 6361812]
[23]
Sahajwalla, C.G.; Helton, E.D.; Purich, E.D.; Hoppel, C.L.; Cabana, B.E. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J. Pharm. Sci., 1995, 84(5), 627-633.
[http://dx.doi.org/10.1002/jps.2600840520] [PMID: 7658356]
[24]
Savic, D.; Ball, V.; Heather, L.C.; Tyler, D. BMJ Publishing Group Ltd and British Cardiovascular Society, 2016.
[25]
Fernández-Ochoa, Á.; Quirantes-Piné, R.; Borrás-Linares, I.; Gemperline, D.; Alarcón Riquelme, M.E.; Beretta, L.; Segura-Carretero, A.; Consortium, P.C. Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients. J. Pharm. Biomed. Anal., 2019, 162, 82-90.
[http://dx.doi.org/10.1016/j.jpba.2018.09.021] [PMID: 30227356]
[26]
Schutte, B.; Carpten, J.; Forus, A.; Gregory, S.; Horii, A.; White, P. Report of the sixth international workshop on human chromosome 1 mapping 2000. Cytogenet. Genome Res., 2001, 92(1-2), 23-48.
[http://dx.doi.org/10.1159/000056867] [PMID: 11306795]
[27]
Chan, I.; Liu, L.; Hamada, T.; Sethuraman, G.; McGrath, J.A. The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp. Dermatol., 2007, 16(11), 881-890.
[http://dx.doi.org/10.1111/j.1600-0625.2007.00608.x] [PMID: 17927570]
[28]
Moy, L.S.; Moy, R.L.; Matsuoka, L.Y.; Ohta, A.; Uitto, J. Lipoid proteinosis: ultrastructural and biochemical studies. J. Am. Acad. Dermatol., 1987, 16(6), 1193-1201.
[http://dx.doi.org/10.1016/S0190-9622(87)70157-1] [PMID: 2439554]
[29]
Fleischmajer, R.; Krieg, T.; Dziadek, M.; Altchek, D.; Timpl, R. Ultrastructure and composition of connective tissue in hyalinosis cutis et mucosae skin. J. Invest. Dermatol., 1984, 82(3), 252-258.
[http://dx.doi.org/10.1111/1523-1747.ep12260200] [PMID: 6199434]
[30]
Bauer, E.A.; Santa-Cruz, D.J.; Eisen, A.Z. Lipoid proteinosis: in vivo and in vitro evidence for a lysosomal storage disease. J. Invest. Dermatol., 1981, 76(2), 119-125.
[http://dx.doi.org/10.1111/1523-1747.ep12525454] [PMID: 7462673]
[31]
Sharma, S.; Black, S.M. Carnitine homeostasis, mitochondrial function and cardiovascular disease. Drug Discov. Today Dis. Mech., 2009, 6(1-4), e31-e39.
[http://dx.doi.org/10.1016/j.ddmec.2009.02.001] [PMID: 20648231]


open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 1
Year: 2020
Published on: 05 September, 2020
Page: [32 - 41]
Pages: 10
DOI: 10.2174/2213235X07666191018120321

Article Metrics

PDF: 15
HTML: 1